Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Cost of TKI Therapy for CML

Published: October 20, 2017

Author: Carlos Harrison

Source: Cancer Therapy Advisor

While tyrosine kinase inhibitors (TKI's) are extending the lives of patients with chronic myeloid leukemia (CML) to spans similar to those of disease-free individuals, missing as few as 3 doses a month can c ... More >>.

Fat Cells Offer Potential for Leukemia Treatment

Published: October 16, 2017

Author: Tina Depko

Source: McMaster University

Researchers with the McMaster Stem Cell and Cancer Research Institute found that boosting adipocytes, or fat cells, located in the bone marrow suppressed cancerous leukemia cells but----in a surprise to the ... More >>.

Genetic Drivers of Lymphoma Identified

Published: October 05, 2017

Source: Duke University Medical Center

An international research effort led by Duke Cancer Institute scientists has been working to better understand the genetic underpinnings of the most prevalent form of lymphoma---diffuse B cell lymphoma, and ... More >>.

Protein Identified that Drives Leukemia

Published: October 03, 2017

Source: Massachusetts General Hospital

A team lead by Massachusetts General Hospital investigators has identified a new cancer-causing pathway behind most cases of an aggressive type of leukemia, findings that could lead to new targeted treatment ... More >>.

Copanlisib for Follicular Lymphoma

Published: September 14, 2017

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

The U.S. Food & Drug Administration (FDA) granted accelerated approval to copanlisib today for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least 2 prior tr ... More >>.

Treatment for Older Lymphoma Patients

Published: September 13, 2017

Author: Carlos Harrison

Source: Cancer Therapy Advisor

Because of factors such as advances in health care and the decreasing overall incidence of cancer, the number of people age 65 and older around the world is expected to be 1.6 billion by 2050, which is twice ... More >>.

AML Response Improved

Published: September 05, 2017

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

Guadecitabine may aid treatment-naïve patients with acute myeloid leukemia (AML) in achieving composite complete responses (CCR), according to a study published in The Lancet Oncology.

... More >>.

FDA Approval of AML Therapy

Published: September 01, 2017

Source: Leukemia & Lymphoma Society

The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), continues today with the U.S. Food & Drug Administration approval of gemtuzumab ozogamicin (Mylotarg). After ... More >>.

New Advance for Acute Lymphoblastic Leukemia

Published: August 17, 2017

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society applauds today's approval by the U.S. Food & Drug Administration (FDA) of inotuzumab ozogamicin (Besponsa) for the treatment of adults with relapsed or refractory B-ce ... More >>.

CAR T Cell Therapy for ALL

Published: August 16, 2017

Author: Paul W. and Holly A. Ewald, PhD

Source: Cancer Therapy Advisor

A U.S. Food & Administration (FDA) panel recently recommended that approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL)----see related article dat ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy